XML 69 R30.htm IDEA: XBRL DOCUMENT
v3.25.1

License Agreements (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
License Agreements |
Schedule of License Agreements | Schedule of License Agreements
Licensor |  | Drug Asset |  | Agreement Date |  | Amendment Date
Elion Oncology, Inc. |  | NGC-Cap (PCS6422) |  | August 23, 2020 |  | May 17, 2022
Ocuphire Pharma, Inc. |  | NGC-Gem (PCS3117) |  | June 16, 2021 |  | N/A
Aposense, Ltd. |  | NGC-Iri (PCS11T) |  | May 24, 2020 |  | N/A
Yuhan Corporation |  | PCS12852 |  | August 19, 2020 |  | N/A
CoNCERT Pharmaceuticals, Inc. |  | PCS499 |  | March 19, 2018 |  | N/A

X
- References No definition available. + Details
Name: | PCSA_DisclosureLicenseAgreementsAbstract
Namespace Prefix: | PCSA_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition License Agreements [Table Text Block] + References No definition available. + Details
Name: | PCSA_LicenseAgreementsTableTextBlock
Namespace Prefix: | PCSA_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration